What Would YOU Charge?

Something that likely went under most peoples’ radar this past week was that the FDA announced the approval of a new drug for multiple sclerosis, Tecfidera, from Biogen Idec. That’s pretty good news for a disease that generally doesn’t have a lot of good news associated with it. Here’s some disease-progression data for it compared…

Rate this:

The Cost of Getting Personal

Early in my scientific career I was in a meeting to decide what one of our department’s new drug discovery projects was going to be. A team made a presentation on a prospective target, which was scientifically solid but was shot down because the potential market was too small. Not enough people had the disease,…

Rate this: